23 May 2013
Keywords: emea, validates, insmed, iplex, ma, usa, says
Article | 10 July 2006
Insmed of the USA says that the European Medicines Agency (EMEA) has validated its application to market Iplex (mecasermin rinfabate [ ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 July 2006
22 May 2013
© 2013 thepharmaletter.com